Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jul '25 Jul 25, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	6,061	5,482	13,447	9,287	8,595	8,596	Upgrade
Market Cap Growth	-47.17%	-59.23%	44.79%	8.05%	-0.00%	192.13%	Upgrade
Last Close Price	7.79	7.03	17.09	11.76	10.82	10.78	Upgrade
PE Ratio	60.51	19.66	13.46	11.13	15.08	25.19	Upgrade
PS Ratio	3.42	2.59	4.63	3.90	4.62	6.66	Upgrade
PB Ratio	0.94	0.78	1.91	1.51	1.51	1.70	Upgrade
Debt / Equity Ratio	0.83	0.83	0.75	0.89	0.99	1.18	Upgrade
Return on Equity (ROE)	-	4.02%	15.19%	14.45%	10.50%	7.49%	Upgrade
Return on Assets (ROA)	-	0.48%	1.85%	1.73%	1.26%	0.87%	Upgrade
Earnings Yield	1.65%	5.09%	7.43%	8.98%	6.63%	3.97%	Upgrade
FCF Yield	-	-17.24%	-54.70%	-67.32%	-29.29%	-12.48%	Upgrade
Dividend Yield	1.56%	-	1.07%	1.33%	0.93%	0.54%	Upgrade
Payout Ratio	-	49.89%	12.10%	8.85%	8.05%	-	Upgrade
Buyback Yield / Dilution	-0.04%	-0.12%	-0.27%	-0.11%	-5.75%	-5.42%	Upgrade
Total Shareholder Return	1.53%	-0.12%	0.80%	1.22%	-4.81%	-4.88%	Upgrade

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.